direct,indirect,issuer_cik,issuer_name,isDirector,isOfficer,isTenPercentOwner,isOther,date,name,accession,officerTitle,predicted_gender,total_stock
22727.0,0.0,1609809,"seres therapeutics, inc.",1,1,0,0,20150629,pomerantz roger,120919115057197,President and CEO,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",1,0,0,0,20150629,behar gregory,120919115057198,,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",1,0,0,0,20150629,kender richard n,120919115057201,,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",1,0,0,0,20150629,hutt peter barton,120919115057205,,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",1,0,0,0,20150629,ausiello dennis a,120919115057206,,male,6890250.0
229673.0,0.0,1609809,"seres therapeutics, inc.",0,1,0,0,20150629,cook david n,120919115057211,See Remarks,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",0,1,0,0,20150629,shaff eric d.,120919115057215,CFO and EVP,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",1,0,0,0,20150629,kim lorence h.,120919115057216,,male,6890250.0
84090.0,0.0,1609809,"seres therapeutics, inc.",0,1,0,0,20150629,aunins john g.,120919115057217,CTO and EVP of Bioprocess Dev.,male,6890250.0
0.0,0.0,1609809,"seres therapeutics, inc.",1,0,0,0,20150629,cautreels werner,120919115057219,,male,6890250.0
